Giuseppe Accogli, SVP of Baxter International Inc. (NYSE:BAX) reportedly Sold 12,670 shares of the company’s stock at an average price of 60.96 for a total transaction amount of $772,363.20 SEC Form These are 1 Sell Rating, 4 Hold …
Baxter International Inc., through its subsidiaries, provides renal and hospital products. The Company operates through two segments: Hospital Products and Renal. Its Hospital Products business manufactures sterile intravenous (IV) solutions …
The announcement was made by Fox chief financial officer Simon Bax, who last summer was upped to president/chief financial officer for Fox Filmed Entertainment. Bax told Daily Variety that the promotions were made to accommodate …
One stock that might be an intriguing choice for investors right now is Baxter International Inc. BAX. This is because this security in the Medical Products space is seeing solid earnings estimate revision activity, and is in great company from …
Headquartered in Deerfield, IL, Baxter International Inc. BAX, a global medical technology company, announced a new oral health project in collaboration with Americares, a health-focused relief and development organization. Notably, share …
Positive tidings on regulatory front, expanding Hospital-Products portfolio, strategic collaborations and strong presence in the international markets are key positives for Baxter's (BAX) Q1 results.